Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.

Authors

Chien-An A. Hu, University of New Mexico - Main Campus
Edward I. Klopfer, University of New Mexico - Main Campus
Patricio E. Ray, Children's National Medical Center, Washington, DCFollow

Document Type

Journal Article

Publication Date

4-5-2012

Journal

FEBS Letters

Volume

Volume 586, Issue 7

Inclusive Pages

947-955

Keywords

Apolipoproteins--metabolism; Carcinoma; Renal Cell--metabolism; Kidney Neoplasms--metabolism; Lipoproteins; HDL--metabolism; Renal Insufficiency; Chronic--metabolism

Comments

This is an open access PubMed Central article. Click on link for full-text access.

Creative Commons License

This work is licensed under a Creative Commons Attribution 3.0 License.

APA Citation

Hu, C. -. A., Klopfer, E. I., & Ray, P. E. (2012). Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease. FEBS Letters, 586(7), 947-955.

Peer Reviewed

1

Open Access

1